NCT00259818 Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00255138 Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects Status WITHDRAWN Phase PHASE3
NCT00253708 Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer Status COMPLETED Phase NA
NCT00253383 Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients Status COMPLETED Phase NA
NCT00252174 MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer Status TERMINATED Phase PHASE2
NCT00251797 A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors Status COMPLETED Phase PHASE1
NCT00251563 Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer. Status UNKNOWN Phase N/A
NCT00250809 Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study Status TERMINATED Phase NA
NCT00250796 Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00250744 Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting Status COMPLETED Phase PHASE2
NCT00250718 Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach Status TERMINATED Phase PHASE2
NCT00250068 Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) Status COMPLETED Phase PHASE2
NCT00250055 Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue Status TERMINATED Phase NA
NCT00250042 A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec Status COMPLETED Phase PHASE2
NCT00250029 Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen Status COMPLETED Phase NA
NCT00249977 Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan Status COMPLETED Phase PHASE1